Pediatric asthma and COVID-19 vaccination: unveiling patterns of hesitancy and acceptance.

Q2 Medicine
Therapeutic Advances in Vaccines and Immunotherapy Pub Date : 2024-11-13 eCollection Date: 2024-01-01 DOI:10.1177/25151355241297874
Marzieh Tavakol, Saber Gharagozlou, Mohammad Abbasi, Zahra Zamani, Mohammad Gharagozlou
{"title":"Pediatric asthma and COVID-19 vaccination: unveiling patterns of hesitancy and acceptance.","authors":"Marzieh Tavakol, Saber Gharagozlou, Mohammad Abbasi, Zahra Zamani, Mohammad Gharagozlou","doi":"10.1177/25151355241297874","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The global COVID-19 pandemic, declared in January 2020, necessitated urgent preventive measures, with vaccination as a key strategy. Despite progress in vaccine development and distribution, widespread hesitancy persists, impeding global disease control efforts. This study specifically explores COVID-19 vaccine hesitancy and acceptance among Iranian children with asthma, aiming to understand factors unique to this subgroup.</p><p><strong>Method: </strong>A cross-sectional investigation was carried out in an allergy clinic in Iran, including a total of 522 asthmatic children between the ages of 5 and 18 years. A comprehensive questionnaire, built upon previous studies, investigated the factors that influence vaccine hesitation and acceptance. Data pertaining to demographics, vaccination status, and factors influencing hesitancy or acceptance were collected.</p><p><strong>Results: </strong>Among the participants, 27.5% were administered the COVID-19 vaccine. Decisions were greatly influenced by family dynamics, with a notable association between parent and child vaccination. Children's vaccination rates were associated with their age and the frequency of COVID-19 diagnosis among their parents. The primary factors motivating individuals to get vaccinated were safety concerns (67.1%) and a strong belief in the severity of COVID-19 (43.4%). On the other hand, vaccine hesitancy resulted from concerns about potential adverse effects (77%), lack of confidence (28.3%), and a belief that children who had already contracted COVID-19 did not require vaccination (22.5%).</p><p><strong>Conclusion: </strong>The study highlights COVID-19 vaccine hesitancy and acceptance among asthmatic children in Iran, emphasizing parental decision-making factors. Tailored interventions are required due to the lower vaccination rate in this specific group. Healthcare providers play a vital role in influencing opinions, urging actions against misinformation, enhancing vaccine understanding, and promoting positive attitudes.</p>","PeriodicalId":33285,"journal":{"name":"Therapeutic Advances in Vaccines and Immunotherapy","volume":"12 ","pages":"25151355241297874"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11561997/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Vaccines and Immunotherapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/25151355241297874","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The global COVID-19 pandemic, declared in January 2020, necessitated urgent preventive measures, with vaccination as a key strategy. Despite progress in vaccine development and distribution, widespread hesitancy persists, impeding global disease control efforts. This study specifically explores COVID-19 vaccine hesitancy and acceptance among Iranian children with asthma, aiming to understand factors unique to this subgroup.

Method: A cross-sectional investigation was carried out in an allergy clinic in Iran, including a total of 522 asthmatic children between the ages of 5 and 18 years. A comprehensive questionnaire, built upon previous studies, investigated the factors that influence vaccine hesitation and acceptance. Data pertaining to demographics, vaccination status, and factors influencing hesitancy or acceptance were collected.

Results: Among the participants, 27.5% were administered the COVID-19 vaccine. Decisions were greatly influenced by family dynamics, with a notable association between parent and child vaccination. Children's vaccination rates were associated with their age and the frequency of COVID-19 diagnosis among their parents. The primary factors motivating individuals to get vaccinated were safety concerns (67.1%) and a strong belief in the severity of COVID-19 (43.4%). On the other hand, vaccine hesitancy resulted from concerns about potential adverse effects (77%), lack of confidence (28.3%), and a belief that children who had already contracted COVID-19 did not require vaccination (22.5%).

Conclusion: The study highlights COVID-19 vaccine hesitancy and acceptance among asthmatic children in Iran, emphasizing parental decision-making factors. Tailored interventions are required due to the lower vaccination rate in this specific group. Healthcare providers play a vital role in influencing opinions, urging actions against misinformation, enhancing vaccine understanding, and promoting positive attitudes.

小儿哮喘与 COVID-19 疫苗接种:揭示犹豫和接受的模式。
背景:2020 年 1 月宣布的 COVID-19 全球大流行要求采取紧急预防措施,而疫苗接种是一项关键战略。尽管疫苗的研发和分发取得了进展,但人们对疫苗仍普遍犹豫不决,阻碍了全球疾病控制工作的开展。本研究专门探讨了伊朗哮喘儿童对 COVID-19 疫苗的犹豫态度和接受程度,旨在了解该亚群的独特因素:方法:在伊朗的一家过敏诊所开展了一项横断面调查,共调查了 522 名 5 至 18 岁的哮喘儿童。在以往研究的基础上编制了一份综合问卷,调查了影响疫苗犹豫不决和接受程度的因素。收集的数据涉及人口统计学、疫苗接种状况以及影响犹豫不决或接受疫苗的因素:结果:在参与者中,27.5% 的人接种了 COVID-19 疫苗。接种决定在很大程度上受家庭动态的影响,父母与子女接种疫苗之间存在显著关联。儿童的接种率与他们的年龄及其父母诊断出 COVID-19 的频率有关。促使个人接种疫苗的主要因素是安全考虑(67.1%)和对 COVID-19 严重性的强烈信念(43.4%)。另一方面,疫苗接种犹豫不决的原因是担心潜在的不良反应(77%)、缺乏信心(28.3%)以及认为已经感染 COVID-19 的儿童不需要接种疫苗(22.5%):结论:本研究强调了伊朗哮喘儿童对 COVID-19 疫苗的犹豫和接受程度,强调了父母的决策因素。由于这一特殊群体的疫苗接种率较低,因此需要采取有针对性的干预措施。医疗保健提供者在影响意见、敦促采取行动消除错误信息、加强对疫苗的了解以及促进积极态度方面发挥着至关重要的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Therapeutic Advances in Vaccines and Immunotherapy
Therapeutic Advances in Vaccines and Immunotherapy Medicine-Pharmacology (medical)
CiteScore
5.10
自引率
0.00%
发文量
15
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信